Flagship-backed Generate raises $273M as its first drugs move to the clinic
BioPharma
Source: biopharmadive.com
Stay updated with breaking news from Mike Nally. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
<strong>Other lives</strong>: Journalist and broadcaster who worked for the BBC and the Observer
Amgen will partner with Generate Biomedicines to discover and create protein therapeutics for five targets across several therapeutic areas and multiple modalities, through a collaboration that could generate up to $3.8 billion-plus for the Flagship Pioneering spinout.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!